{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:56:48Z","timestamp":1783483008424,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clae.2024.102148","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:41:13Z","timestamp":1711010473000},"page":"102148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"47","author":[{"given":"Syed","family":"Muhammad Muneeb Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Fareed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sohaib Asghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munazza","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehajpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2024.102148_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.592759","article-title":"Association between demodex infestation and Ocular Surface Microbiota in patients with demodex Blepharitis","volume":"7","author":"Yan","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.clae.2024.102148_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/OPTO.S142708","article-title":"Demodex blepharitis: clinical perspectives","volume":"10","author":"Fromstein","year":"2018","journal-title":"Clin Optom"},{"key":"10.1016\/j.clae.2024.102148_b0015","doi-asserted-by":"crossref","unstructured":"Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1). Cornea, Publish Ahead of Print; 2022. https:\/\/doi.org\/10.1097\/ico.0000000000003097.","DOI":"10.1097\/ICO.0000000000003097"},{"issue":"1","key":"10.1016\/j.clae.2024.102148_b0020","doi-asserted-by":"crossref","first-page":"P56","DOI":"10.1016\/j.ophtha.2018.10.019","article-title":"Blepharitis preferred Practice pattern\u00ae","volume":"126","author":"Amescua","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2024.102148_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-023-02500-4","article-title":"Clinical diagnosis and management of demodex blepharitis: the demodex expert panel on treatment and eyelid health (DEPTH)","author":"Ayres","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.clae.2024.102148_b0030","article-title":"Demodex infestation -","author":"Yen","year":"2023","journal-title":"EyeWiki [internet] Eyewikiorg"},{"key":"10.1016\/j.clae.2024.102148_b0035","doi-asserted-by":"crossref","unstructured":"Gaddie, I. B., Donnenfeld, E. D., Karpecki, P., Vollmer, P., Berdy, G. J., Peterson, J. D., Simmons, B., Edell, A. R. P., Whitson, W. E., Ciolino, J. B., Baba, S. N., Holdbrook, M., Trevejo, J., Meyer, J., & Yeu, E. (2023). Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2). Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2023.05.030.","DOI":"10.1016\/j.ophtha.2023.05.030"},{"key":"10.1016\/j.clae.2024.102148_b0040","article-title":"Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double-masked clinical trial","volume":"101492","author":"Gonzalez-Salinas","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.clae.2024.102148_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3862684","article-title":"Safety and efficacy of topical lotilaner ophthalmic solution 0.25% for the treatment of demodex blepharitis: a pilot study","author":"Gonzalez-Salinas","year":"2021","journal-title":"J Ophthalmol"},{"issue":"71","key":"10.1016\/j.clae.2024.102148_b0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"issue":"343","key":"10.1016\/j.clae.2024.102148_b0055","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clae.2024.102148_b0060","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.clae.2024.102148_b0065","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"10.1016\/j.clae.2024.102148_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.clae.2024.102148_b0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clae.2024.102148_b0080","first-page":"1","article-title":"Treatment of demodex Blepharitis: a prospective, randomized, controlled, double-masked clinical trial Comparing topical lotilaner ophthalmic solution, 0.25% eyedrops to vehicle","author":"Yeu","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clae.2024.102148_b0085","doi-asserted-by":"crossref","unstructured":"Sadri E, Paauw JD, Ciolino JB, et al. Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study. Cornea. Published online February 9, 2024.","DOI":"10.1097\/ICO.0000000000003484"},{"key":"10.1016\/j.clae.2024.102148_b0090","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/OPTH.S354692","article-title":"The prevalence of demodex Blepharitis in US eye Care clinic patients as determined by Collarettes: a pathognomonic sign","volume":"16","author":"Trattler","year":"2022","journal-title":"Clin Ophthalmol (Auckland, N.Z.)"},{"key":"10.1016\/j.clae.2024.102148_b0095","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1167\/iovs.05-0275","article-title":"High prevalence of demodex in eyelashes with cylindrical dandruff","volume":"46","author":"Gao","year":"2005","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.clae.2024.102148_b0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/bjophthalmol-2014-305671","article-title":"In vivo confocal microscopy as a novel and reliable tool for the diagnosis of demodex eyelid infestation","volume":"99","author":"Randon","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2024.102148_b0105","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/ICO.0000000000001361","article-title":"Ocular demodicosis as a potential cause of ocular surface inflammation","volume":"36","author":"Luo","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2024.102148_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2019.03.007","article-title":"Demodex mite infestation and its associations with tear film and ocular surface parameters in patients with ocular discomfort","volume":"204","author":"Rabensteiner","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2024.102148_b0115","first-page":"1236","article-title":"Prevalence of demodex colonization in patients presenting to an outpatient clinic","volume":"62","author":"Teo","year":"2021","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"6","key":"10.1016\/j.clae.2024.102148_b0120","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajo.2010.11.024","article-title":"Clinical treatment of Ocular demodex folliculorum by systemic ivermectin","volume":"151","author":"Holzchuh","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2024.102148_b0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bjo.2010.201194","article-title":"Grisolia ABD, et alThe efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for demodex spp","volume":"95","author":"Filho","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2024.102148_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101453","article-title":"Interventions for demodex blepharitis and their effectiveness: a systematic review and meta-analysis","volume":"44","author":"Martinez-Pulgarin","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"10.1016\/j.clae.2024.102148_b0135","first-page":"CD013697","article-title":"Oral antibiotics for chronic blepharitis","volume":"6","author":"Onghanseng","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"78","key":"10.1016\/j.clae.2024.102148_b0140","first-page":"300","article-title":"Blepharitis: epidemiology, etiology, clinical presentations, treatment and evolution of our patients","volume":"4","author":"Dias","year":"2019","journal-title":"Rev Bras Oftalmol"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T18:58:16Z","timestamp":1718477896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1367048424000377"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102148","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102148"}}